Skip to main content

View full-text article in PMC

. 2011 Sep;72(3):454–464. doi: 10.1111/j.1365-2125.2011.03992.x

Table 1.

Study characteristics and demographics

	*PENTA 15*	*PENTA 13*
	[mean (range)]	[mean (range)]
Number of patients	23	14
Ethnicity	16 African, 4 Caucasian, 2 Other^*	African
Age (years)	1.8 (0.43–2.89)	5.9 (2.14–12.84)
Weight (kg)	11.6 (7.4–15.9)	23.8 (13.7–60.5)
Height (cm)	81 (62–98)	115 (89–164)
BMI (kg cm⁻²)	17.8 (15.0–24.2)	16.8 (13.8–22.4)
Creatinine clearance (dl h⁻¹)	31.7 (16.4–50.4)	81 (59–159)
Male/Female	12/11	8/6
Normal/Fasted	8/5^*	14/0
Samples	4–9	9
Administration route	Oral
Dosage form	20 mg ml⁻¹ solution
Dose	8–16 mg kg⁻¹

^*

indicates missing data.